ANNE MOGAVERO: Open Payments
NPI 1205379666 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 9 payments from 8 companies in 2025. Trend: 2023 $1,060 · 2024 $918 · 2025 $249
Food & beverage: $201Education: $48
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $80 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| GENZYME CORPORATION | 1 | $26 |
| Incyte Corporation | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: DUPIXENT, ILUMYA, OPZELURA, COSENTYX, NEMLUVIO, Zoryve, Sotyktu.
Industry payments across NY — which companies pay providers there.
